Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Sphenopalatine ganglion stimulation after stroke, promising but not yet ready for adoption.

Sandset EC, Ford GA.

Lancet. 2019 Jul 20;394(10194):189-190. doi: 10.1016/S0140-6736(19)31412-6. No abstract available.

PMID:
31327352
2.

Dopamine Augmented Rehabilitation in Stroke (DARS): a multicentre double-blind, randomised controlled trial of co-careldopa compared with placebo, in addition to routine NHS occupational and physical therapy, delivered early after stroke on functional recovery.

Ford GA, Bhakta BB, Cozens A, Cundill B, Hartley S, Holloway I, Meads D, Pearn J, Ruddock S, Sackley CM, Saloniki EC, Santorelli G, Walker MF, Farrin AJ.

Southampton (UK): NIHR Journals Library; 2019 Jul.

3.

Maximising access to thrombectomy services for stroke in England: A modelling study.

Allen M, Pearn K, James M, Ford GA, White P, Rudd AG, McMeekin P, Stein K.

Eur Stroke J. 2019 Mar;4(1):39-49. doi: 10.1177/2396987318785421. Epub 2018 Jul 19.

4.

Management of intravenous thrombolysis in case of mechanical thrombectomy: global real-life data from SITS centers.

Feil K, Dieterich M, Wollenweber FA, Ahmed N, Kellert L; SITS investigators.

J Neurol. 2019 Sep;266(9):2324-2326. doi: 10.1007/s00415-019-09383-0. Epub 2019 May 30. No abstract available.

PMID:
31147765
5.

Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.

Rodgers H, Bosomworth H, Krebs HI, van Wijck F, Howel D, Wilson N, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Fernandez-Garcia C, Finch T, Ford GA, Francis R, Hogg S, Hughes N, Price CI, Ternent L, Turner DL, Vale L, Wilkes S, Shaw L.

Lancet. 2019 Jul 6;394(10192):51-62. doi: 10.1016/S0140-6736(19)31055-4. Epub 2019 May 22.

6.

Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.

Ford GA, Bhakta BB, Cozens A, Hartley S, Holloway I, Meads D, Pearn J, Ruddock S, Sackley CM, Saloniki EC, Santorelli G, Walker MF, Farrin AJ.

Lancet Neurol. 2019 Jun;18(6):530-538. doi: 10.1016/S1474-4422(19)30147-4.

7.

Delayed Revascularization in Patients With Basilar Artery Occlusion.

Dumont AS, Ford GA.

Stroke. 2019 Jun;50(6):1327-1328. doi: 10.1161/STROKEAHA.119.025499. Epub 2019 May 16. No abstract available.

PMID:
31092160
8.

Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register.

Mazya MV, Cooray C, Lees KR, Toni D, Ford GA, Bar M, Frol S, Moreira T, Sekaran L, Švigelj V, Wahlgren N, Ahmed N.

Eur Stroke J. 2018 Mar;3(1):29-38. doi: 10.1177/2396987317746003. Epub 2017 Nov 29.

9.

Are there opportunities for a closer collaboration on clinical stroke research in Europe?

Berge E, Ford GA, Stapf C, Al-Shahi Salman R, Fischer U, Coveney S, Weimar C, Arnold M, Arsovska A, Lemmens R, Nederkoorn PJ, Kelly PJ.

Eur Stroke J. 2018 Mar;3(1):22-28. doi: 10.1177/2396987317747456. Epub 2017 Dec 11.

10.

Organizational innovation for developing new medicines that target aging and age-related conditions.

Ford GA, Lord JM, Ferguson MA, Bountra C, Le Couteur DG.

J Gerontol A Biol Sci Med Sci. 2019 Mar 6. pii: glz062. doi: 10.1093/gerona/glz062. [Epub ahead of print] No abstract available.

PMID:
30838376
11.

Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.

Chamorro Á, Brown S, Amaro S, Hill MD, Muir KW, Dippel DWJ, van Zwam W, Butcher K, Ford GA, den Hertog HM, Mitchell PJ, Demchuk AM, Majoie CBLM, Bracard S, Sibon I, Jadhav AP, Lara-Rodriguez B, van der Lugt A, Osei E, Renú A, Richard S, Rodriguez-Luna D, Donnan GA, Dixit A, Almekhlafi M, Deltour S, Epstein J, Guillon B, Bakchine S, Gomis M, du Mesnil de Rochemont R, Lopes D, Reddy V, Rudel G, Roos YBWEM, Bonafe A, Diener HC, Berkhemer OA, Cloud GC, Davis SM, van Oostenbrugge R, Guillemin F, Goyal M, Campbell BCV, Menon BK; HERMES Collaborators.

Stroke. 2019 Mar;50(3):690-696. doi: 10.1161/STROKEAHA.118.023769.

PMID:
30777000
12.

The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes.

Robinson TG, Wang X, Durham AC, Ford GA, Liao J, Littlewood S, Roffe C, White P, Chalmers J, Anderson CS; ENCHANTED Investigators.

Health Res Policy Syst. 2019 Feb 13;17(1):19. doi: 10.1186/s12961-019-0417-2.

13.

Paramedic Acute Stroke Treatment Assessment (PASTA): study protocol for a randomised controlled trial.

Price CI, Shaw L, Dodd P, Exley C, Flynn D, Francis R, Islam S, Javanbakht M, Lakey R, Lally J, McClelland G, McMeekin P, Rodgers H, Snooks H, Sutcliffe L, Tyrell P, Vale L, Watkins A, Ford GA.

Trials. 2019 Feb 12;20(1):121. doi: 10.1186/s13063-018-3144-z.

14.

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.

Spence JD, Viscoli CM, Inzucchi SE, Dearborn-Tomazos J, Ford GA, Gorman M, Furie KL, Lovejoy AM, Young LH, Kernan WN; IRIS Investigators.

JAMA Neurol. 2019 May 1;76(5):526-535. doi: 10.1001/jamaneurol.2019.0079. Erratum in: JAMA Neurol. 2019 Mar 18;:.

PMID:
30734043
15.

Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.

Bourcier R, Goyal M, Liebeskind DS, Muir KW, Desal H, Siddiqui AH, Dippel DWJ, Majoie CB, van Zwam WH, Jovin TG, Levy EI, Mitchell PJ, Berkhemer OA, Davis SM, Derraz I, Donnan GA, Demchuk AM, van Oostenbrugge RJ, Kelly M, Roos YB, Jahan R, van der Lugt A, Sprengers M, Velasco S, Lycklama À Nijeholt GJ, Ben Hassen W, Burns P, Brown S, Chabert E, Krings T, Choe H, Weimar C, Campbell BCV, Ford GA, Ribo M, White P, Cloud GC, San Roman L, Davalos A, Naggara O, Hill MD, Bracard S; HERMES Trialists Collaboration.

JAMA Neurol. 2019 Apr 1;76(4):405-411. doi: 10.1001/jamaneurol.2018.4510. Erratum in: JAMA Neurol. 2019 May 28;:.

PMID:
30667465
16.

OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.

Sheppard JP, Burt J, Lown M, Temple E, Benson J, Ford GA, Heneghan C, Hobbs FDR, Jowett S, Little P, Mant J, Mollison J, Nickless A, Ogburn E, Payne R, Williams M, Yu LM, McManus RJ.

BMJ Open. 2018 Oct 4;8(9):e022930. doi: 10.1136/bmjopen-2018-022930.

17.

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.

Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators.

Lancet Neurol. 2018 Oct;17(10):895-904. doi: 10.1016/S1474-4422(18)30242-4. Epub 2018 Sep 18. Erratum in: Lancet Neurol. 2018 Dec;17(12):e2-e3.

PMID:
30264728
18.

A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke.

De Brún A, Flynn D, Ternent L, Price CI, Rodgers H, Ford GA, Rudd M, Lancsar E, Simpson S, Teah J, Thomson RG.

BMC Health Serv Res. 2018 Jun 22;18(1):483. doi: 10.1186/s12913-018-3305-5.

19.

Estimating the number of UK stroke patients eligible for endovascular thrombectomy.

McMeekin P, White P, James MA, Price CI, Flynn D, Ford GA.

Eur Stroke J. 2017 Dec;2(4):319-326. doi: 10.1177/2396987317733343. Epub 2017 Oct 4.

20.

Advances in Stroke 2017.

Bernhardt J, Zorowitz RD, Becker KJ, Keller E, Saposnik G, Strbian D, Dichgans M, Woo D, Reeves M, Thrift A, Kidwell CS, Olivot JM, Goyal M, Pierot L, Bennett DA, Howard G, Ford GA, Goldstein LB, Planas AM, Yenari MA, Greenberg SM, Pantoni L, Amin-Hanjani S, Tymianski M.

Stroke. 2018 May;49(5):e174-e199. doi: 10.1161/STROKEAHA.118.021380. Epub 2018 Apr 18. Review. No abstract available.

PMID:
29669874
21.

Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial.

Croall ID, Tozer DJ, Moynihan B, Khan U, O'Brien JT, Morris RG, Cambridge VC, Barrick TR, Blamire AM, Ford GA, Markus HS; PRESERVE Study Team.

JAMA Neurol. 2018 Jun 1;75(6):720-727. doi: 10.1001/jamaneurol.2017.5153.

22.

Klinefelter Syndrome.

Los E, Ford GA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Mar 22.

23.

A Delphi study and ranking exercise to support commissioning services: future delivery of Thrombectomy services in England.

Halvorsrud K, Flynn D, Ford GA, McMeekin P, Bhalla A, Balami J, Craig D, White P.

BMC Health Serv Res. 2018 Feb 22;18(1):135. doi: 10.1186/s12913-018-2922-3.

24.

Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.

Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Dávalos A, Majoie CBLM, van der Lugt A, Ford GA, de la Ossa NP, Kelly M, Bourcier R, Donnan GA, Roos YBWEM, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarençon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators.

Lancet Neurol. 2018 Jan;17(1):47-53. doi: 10.1016/S1474-4422(17)30407-6. Epub 2017 Dec 16. Erratum in: Lancet Neurol. 2019 Mar;18(3):e2.

PMID:
29263006
25.

European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke.

Kobayashi A, Czlonkowska A, Ford GA, Fonseca AC, Luijckx GJ, Korv J, de la Ossa NP, Price C, Russell D, Tsiskaridze A, Messmer-Wullen M, De Keyser J.

Eur J Neurol. 2018 Mar;25(3):425-433. doi: 10.1111/ene.13539. Epub 2018 Jan 12. Review. Erratum in: Eur J Neurol. 2018 Oct;25(10):1303.

PMID:
29218822
26.

Intra-arterial mechanical thrombectomy stent retrievers and aspiration devices in the treatment of acute ischaemic stroke: A systematic review and meta-analysis with trial sequential analysis.

Flynn D, Francis R, Halvorsrud K, Gonzalo-Almorox E, Craig D, Robalino S, McMeekin P, Cora A, Balami J, Ford GA, White P.

Eur Stroke J. 2017 Dec;2(4):308-318. doi: 10.1177/2396987317719362. Epub 2017 Jul 10. Review.

27.

When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study.

Barton P, Sheppard JP, Penaloza-Ramos CM, Jowett S, Ford GA, Lasserson D, Mant J, Mellor RM, Quinn T, Rothwell PM, Sandler D, Sims D, McManus RJ; BBC CLAHRC investigators.

BMJ Open. 2017 Nov 25;7(11):e018189. doi: 10.1136/bmjopen-2017-018189.

28.

Complications of endovascular treatment for acute ischemic stroke: Prevention and management.

Balami JS, White PM, McMeekin PJ, Ford GA, Buchan AM.

Int J Stroke. 2018 Jun;13(4):348-361. doi: 10.1177/1747493017743051. Epub 2017 Nov 24. Review.

PMID:
29171362
29.

Integrating acute stroke telemedicine consultations into specialists' usual practice: a qualitative analysis comparing the experience of Australia and the United Kingdom.

Bagot KL, Cadilhac DA, Bladin CF, Watkins CL, Vu M, Donnan GA, Dewey HM, Emsley HCA, Davies DP, Day E, Ford GA, Price CI, May CR, McLoughlin ASR, Gibson JME, Lightbody CE; VST and ASTUTE investigators.

BMC Health Serv Res. 2017 Nov 21;17(1):751. doi: 10.1186/s12913-017-2694-1.

30.

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.

Alzheimers Dement. 2018 Mar;14(3):280-292. doi: 10.1016/j.jalz.2017.09.007. Epub 2017 Oct 19.

PMID:
29055812
31.

Taking care of volunteers in a stroke trial: a new assisted-management strategy.

Stuart AC, Sico JJ, Viscoli CM, Tayal AH, Inzucchi SE, Ford GA, Furie KL, Cote R, Spence JD, Tanne D, Kernan WN.

Stroke Vasc Neurol. 2016 Oct 25;1(3):108-114. doi: 10.1136/svn-2016-000029. eCollection 2016 Sep.

32.

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.

Furie KL, Viscoli CM, Gorman M, Ford GA, Young LH, Inzucchi SE, Guarino PD, Lovejoy AM, Conwit R, Tanne D, Kernan WN; IRIS Trial Investigators.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):21-27. doi: 10.1136/jnnp-2017-316361. Epub 2017 Sep 22.

PMID:
28939682
33.

Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs >3-4.5 hours.

Ahmed N, Lees KR, Ringleb PA, Bladin C, Collas D, Toni D, Ford GA; The SITS Investigators.

Neurology. 2017 Oct 10;89(15):1561-1568. doi: 10.1212/WNL.0000000000004499. Epub 2017 Sep 8.

PMID:
28887377
34.

Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.

Thorén M, Azevedo E, Dawson J, Egido JA, Falcou A, Ford GA, Holmin S, Mikulik R, Ollikainen J, Wahlgren N, Ahmed N.

Stroke. 2017 Sep;48(9):2464-2471. doi: 10.1161/STROKEAHA.117.018223. Epub 2017 Aug 3.

PMID:
28775140
35.

Robot Assisted Training for the Upper Limb after Stroke (RATULS): study protocol for a randomised controlled trial.

Rodgers H, Shaw L, Bosomworth H, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Eyre J, Finch T, Ford GA, Hislop J, Hogg S, Howel D, Hughes N, Krebs HI, Price C, Rochester L, Stamp E, Ternent L, Turner D, Vale L, Warburton E, van Wijck F, Wilkes S.

Trials. 2017 Jul 20;18(1):340. doi: 10.1186/s13063-017-2083-4.

36.

Galactose 1 Phosphate Uridyltransferase Deficiency (Galactosemia).

Los E, Ford GA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 2.

37.

CTA in acute stroke: short intensive training intervention is highly effective in improving radiologists' performance.

Cora EA, Ford GA, Flynn D, Gonsalves P, White P.

Clin Radiol. 2017 Oct;72(10):871-877. doi: 10.1016/j.crad.2017.04.015. Epub 2017 May 30.

PMID:
28576436
38.

Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).

Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC; ARTSS-2 Investigators.

Stroke. 2017 Jun;48(6):1608-1616. doi: 10.1161/STROKEAHA.117.016720. Epub 2017 May 15.

39.

Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.

Croall ID, Lohner V, Moynihan B, Khan U, Hassan A, O'Brien JT, Morris RG, Tozer DJ, Cambridge VC, Harkness K, Werring DJ, Blamire AM, Ford GA, Barrick TR, Markus HS.

Clin Sci (Lond). 2017 Jun 7;131(12):1361-1373. doi: 10.1042/CS20170146. Print 2017 Jun 1.

40.

Increasing value and reducing waste in stroke research.

Berge E, Al-Shahi Salman R, van der Worp HB, Stapf C, Sandercock P, Sprigg N, Macleod MR, Kelly PJ, Nederkoorn PJ, Ford GA; European Stroke Organisation Trials Network Committee.

Lancet Neurol. 2017 May;16(5):399-408. doi: 10.1016/S1474-4422(17)30078-9. Review.

PMID:
28414653
41.

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, Yavagal DR, Uchino K, Liebeskind DS, Auchus AP, Sen S, Sila CA, Vest JD, Mays RW.

Lancet Neurol. 2017 May;16(5):360-368. doi: 10.1016/S1474-4422(17)30046-7. Epub 2017 Mar 17.

PMID:
28320635
42.

4D flow MRI assessment of right atrial flow patterns in the normal heart - influence of caval vein arrangement and implications for the patent foramen ovale.

Parikh JD, Kakarla J, Keavney B, O'Sullivan JJ, Ford GA, Blamire AM, Hollingsworth KG, Coats L.

PLoS One. 2017 Mar 10;12(3):e0173046. doi: 10.1371/journal.pone.0173046. eCollection 2017.

43.

Understanding the relationship between costs and the modified Rankin Scale: A systematic review, multidisciplinary consensus and recommendations for future studies.

Wilson A, Bath PM, Berge E, Cadilhac DA, Cuche M, Ford GA, Macisaac R, Quinn TJ, Taylor M, Walters M, Wolff C, Lees KR; for the ESO-VISTA Health Economics Working Group.

Eur Stroke J. 2017 Mar;2(1):3-12. doi: 10.1177/2396987316684705. Epub 2016 Dec 22.

44.

Intracerebral hemorrhage location and outcome among INTERACT2 participants.

Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators.

Neurology. 2017 Apr 11;88(15):1408-1414. doi: 10.1212/WNL.0000000000003771. Epub 2017 Feb 24.

45.

A review of enhanced paramedic roles during and after hospital handover of stroke, myocardial infarction and trauma patients.

Flynn D, Francis R, Robalino S, Lally J, Snooks H, Rodgers H, McClelland G, Ford GA, Price C.

BMC Emerg Med. 2017 Feb 23;17(1):5. doi: 10.1186/s12873-017-0118-5. Review.

46.

Referral pathways for patients with TIA avoiding hospital admission: a scoping review.

Evans BA, Ali K, Bulger J, Ford GA, Jones M, Moore C, Porter A, Pryce AD, Quinn T, Seagrove AC, Snooks H, Whitman S, Rees N; TIER Trial Research Management Group.

BMJ Open. 2017 Feb 14;7(2):e013443. doi: 10.1136/bmjopen-2016-013443. Review.

47.

Factors that influence variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke: results of a discrete choice experiment.

Thomson RG, De Brún A, Flynn D, Ternent L, Price CI, Rodgers H, Ford GA, Rudd M, Lancsar E, Simpson S, Teah J.

Southampton (UK): NIHR Journals Library; 2017 Jan.

48.

Factors that influence clinicians' decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment.

De Brún A, Flynn D, Ternent L, Price CI, Rodgers H, Ford GA, Rudd M, Lancsar E, Simpson S, Teah J, Thomson RG.

Int J Stroke. 2018 Jan;13(1):74-82. doi: 10.1177/1747493017690755. Epub 2017 Jan 30.

PMID:
28134031
49.

Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.

Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators.

PLoS One. 2017 Jan 17;12(1):e0164608. doi: 10.1371/journal.pone.0164608. eCollection 2017.

50.

Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study)).

Olsen K, Howel D, Barber R, Ford GA, Gallagher P, McAllister-Williams RH, Nilsson J, O'Brien J, Parker J, Thomas A.

Pilot Feasibility Stud. 2015 Dec 22;1:44. doi: 10.1186/s40814-015-0042-y. eCollection 2015.

Supplemental Content

Loading ...
Support Center